Baseball players peculiarly pitchers practise tremendous forces across the within business office of their elbows when throwing. The within business office of the elbow is supported yesteryear a stout ligament---the ulnar collateral ligament. Repetitive trauma inwards the shape of pitching or an astute severe injury such every mo an elbow dislocation tin dismiss upshot inwards a consummate tear of this of import stabilizing ligament. Pitchers who sustain a consummate tear are typically treated alongside "Tommy John" surgery---reconstruction of the ulnar collateral ligament.
In athletes alongside partial injuries to this ligament, however, platelet rich plasma is emerging every mo an choice handling to surgery. In a written report presented at the American Academy of Orthopedic Surgery (2012) by Dr. Scott Crow et al, the value of PRP every mo a handling for this injury was discussed. 94% of athletes returned to play within 10 weeks when treated alongside PRP.
"...researchers followed 17 athletes alongside a partial UCL tear. All patients had failed conservative treatment, including residuum too physical therapy. Baseline questionnaires, including the Kerlan-Jobe Shoulder too Elbow Score (KJOC Score) too Disability of the Arm, Shoulder, too Hand Score (DASH Score) were completed for each patient prior to the PRP injection. Each patient underwent a unmarried PRP injection at the ulnar collateral ligament nether ultrasound guidance.
At an average follow-up of xviii weeks (range 12-46 weeks), sixteen of 17 athletes had returned to play. The average fourth dimension to furnish to play was 10 weeks (range 8-12 weeks). The average KJOC Score improved from 47 to 93, p=.0001. The average DASH Score improved from 24 to 3, p=.003. The Sports Module of the DASH questionnaire improved from 74 to 6, p=.0001.
"There is piffling data inwards the literature regarding non-surgical handling of UCL tears. Our results present that PRP may endure an pick to furnish players to the plain without having to house them nether the knife," said Crow." See Full Press Release
No comments:
Post a Comment